InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
2
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-51.3%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the full record of transactions filed by Civik Thomas, 董事. Director active across 2 companies, notably Repare Therapeutics Inc.. In total, 5 disclosures have been recorded. Split: 2 buys · 0 sell. Total volume traded: €362k. History available since 16 November 2021. The latest transaction was filed on 24 March 2023 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Civik Thomas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报5 总计
7,500 股Common SharesSEC:0001723092-26-000002:0
139,355 股0Common StockSEC:0001209191-23-021404:0
66,831 股0Common StockSEC:0001140361-22-012919:0
15,700 股@ US$12.74100.0% 占其流量Common StockSEC:0000899243-21-045363:0
标准退出：2022年2月16日 (T+90)
7,500 股@ US$28.08100.0% 占其流量Common SharesSEC:0001209191-21-065517:0
标准退出：2022年2月14日 (T+90)
5 条申报中的 5 条
About Civik Thomas
Thomas Civik is a Director at Repare Therapeutics Inc. and Pyxis Oncology, Inc. He brings his biotechnology expertise to the board, participating in strategic decision-making for the company. His experience is essential in guiding innovation.
